Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist, and Executive Director of Employer Services at the City of Hope Comprehensive Cancer Center in Duarte, CA.

Video Presentation on Management Options for Stage IIIA NSCLC
Mon, 07/20/2009 - 07:49
Author
Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services, Founder, President and CEO of GRACE

With special thanks to the support of the Lung Cancer Connection and longtime member and friend of GRACE Myrtle Chidester, I am very happy to offer a new video podcast presentation on one of the most controversial and interesting areas of lung cancer management. Stage IIIA NSCLC with N2 mediastinal node involvement generates debates among the experts as well as at local hospital tumor boards everywhere, on a weekly basis. There is a little bit of evidence to support several views of how best to treat such patients, while in fact there is a lot of hoterogeneity within the stage IIIA N2 population. For this reason, we often manage people on a case by case basis, which may well be the optimal strategy after all.

Here is a general summary of the current state of the field. Below is the link to the audio version, the transcript and figures, and the video version at the bottom.

[powerpress]

Stage IIIA Vodcast Audio

Stage IIIA Vodcast Figures

Stage IIIA Vodcast Transcript

Next Previous link

Previous PostNext Post

Related Content

Image
Targeted Therapies Forum presented in English
Video
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience, as well as a presentation by a patient advocate, Ivy Elkins. To watch the complete playlist click here.
Image
Targeted Therapies Forum presented in English
Video
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience, as well as a presentation by a patient advocate, Ivy Elkins. To watch the complete playlist click here.
Image
Targeted Therapies Forum presented in English
Video
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q&A with the audience, as well as a presentation by a patient advocate, Ivy Elkins. To watch the complete playlist click here.

Forum Discussions

ONKTALK is tomorrow. 

I hope to see you there.

The forum is now available on demand here.  Don't hesitate to ask questions as they come up. 

Take care,

Janine

Hi happybluesun,  Welcome to Grace.   I'm sorry your mom is going through this. 

 

Driver mutations are mutations that drive (or cause) the cancer.  Having more than one driver mutation is...

Hi Janine, thank you very much for your reply. As of June 2023, my mom has been prescribed Almonertibi Mesilate Tablet, a targeted therapy medicine made by the Chinese company Haosen...

Hi happybluesun, How is your mom feeling?  Her case has specific components including the rare combo of mutations situation we can't help with a specific "this is standard of care".  She...

I agree with you that we should explore all possible TKI options before switching to another one. When you mention 'TKI options,' are you referring to various brands produced by different...

Recent Comments

JOIN THE CONVERSATION
The forum is now available…
By JanineT GRACE … on Mon, 09/25/2023 - 14:10
Reminder
By JanineT GRACE … on Fri, 09/22/2023 - 15:50
Yes, all of the brand-named…
By JanineT GRACE … on Sun, 09/17/2023 - 14:43
TKI options
By happybluesun on Sun, 09/17/2023 - 10:55